Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies

Biometrika

Volumn 95, Issue 3, 2008, Pages 695-707

  Feng, Wentao ^a   Wahed, Abdus S ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adaptive treatment strategy; Brownian motion; Censoring distribution; Counting process; Proportional hazard; Sample size formula; Supremum log rank statistic; Survival function; Two stage design

Indexed keywords

EID: 50949113250     PISSN: 00063444     EISSN: 14643510     Source Type: Journal    
DOI: 10.1093/biomet/asn025     Document Type: Article

References (19)

1. ENG, K. H. & KOSOROK, M. R. (2005). A sample size formula for the supremum log-rank statistic. Biometrics 61, 6-91.
2. FLEMING, T. R. & HARRINGTON, D. P. (1991). Counting Processes and Survival Analysis. New York: Wiley.
3. GUO, X. & TSIATIS, A. (2005). A weighted risk set estimator for survival distributions in two-stage randomization designs with censored survival data. Int. J. Biostatist. 1, 1-15.
4. HOLLAND, P. W. (1986). Statistics and causal inference. J. Am. Statist. Assoc. 81, 945-60.
5. HUANG, X., CORMIER, J. N. & PISTERS, P. W. T. (2006). Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases. Biometrics 62, 901-9.
6. KOSOROK, M. R. & LIN, C. Y. (1999). The versatility of function-indexed weighted log-rank statistics. J. Am. Statist. Assoc. 94, 320-32.
7. LOKHNYGINA, Y. & HELTERBRAND, J. D. (2007). Cox regression methods for two-stage randomization designs. Biometrics 63, 422-8.
8. LUNCEFORD, J. K., DAVIDIAN, M. & TSIATIS, A. A. (2002). Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 58, 48-57.
9. MURPHY, S. (2003). Optimal dynamic treatment regimes (with discussion). J. R. Statist. Soc. B 65, 331-66.
10. MURPHY, S. (2005). An experimental design for the development of adaptive treatment strategies. Statist. Med. 24, 1455-81.
11. R DEVELOPMENT CORE TEAM (2005). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
12. RUBIN, D. B. (1974). Estimating causal effects of treatments in randomized and non-randomized studies. J. Educ. sychol. 66, 688-701.
13. RUSH, A. J., FAVA, M., WISNIEWSKI, S. R., LAVORI, P. W., TRIVEDI, M. H., SACKEIM, H. A., THASE, M. E., NIERENBERG, A. A., QUITKIN, F. M. & KASHNER, T. M. (2004). Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Contr. Clin. Trials 25, 119-42.
14. SCHOENFELD, D. A. (1983). Sample-size formula for the proportional-hazards regression model. Biometrics 39, 499-503.
15. STONE, R. M., BERG, D. T., GEORGE, S. L., DODGE, R. K., PACIUCCI, P. A., SCHULMAN, P. P., LEE, E. J., MOORE, J. O., POWELL, B. L., BAER, M. R., BLOOMFIELD, C. D. & SCHIFFER, C. A. (2001). Postremission therapy in older patients with de novo acute myeloid leukemia: A randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine . Blood 98, 548-53.
16. THALL, P. F., SUNG, H.-G. & ESTEY, E. H. (2002). Selecting therapeutic strategies based on efficacy and death in multi-course clinical trials. J. Am. Statist. Assoc. 97, 29-39.
17. WAHED, A. S. & TSIATIS, A. A. (2004). Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics 60, 124-33.
18. WAHED, A. S. & TSIATIS, A. A. (2006). Semiparametric efficient estimation of survival distributions in two-stage randomization designs in clinical trials with censored data. Biometrika 93, 163-77.
19. WINTER, J. N., WELLER, E. A., HORNING, S. J., KRAJEWSKA, M., VARIAKOJIS, D., HABERMANN, T. M., FISHER, R. I., KURTIN, P. J., MACON, W. R., CHHANABHAI, M., FELGAR, R. E., HSI, E. D., MEDEIROS, L. J., WEICK, J. K., REED, J. C. & GASCOYNE, R. D. (2006). Prognostic significance of BCL-6 protein expression in DLBCL treated with CHOP or R-CHOP: A prospective correlative study. Blood 107, 4207-13.